Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
AF and Mortality in MI Patients
Author(s): Ferdinand Bauke , Christa Meisinger , Philip Raake , et al Added: 1 year ago

Electrophysiology & Arrhythmia
AβYSS: Beta-Blocker Interruption Post-MI Raises BP, Heart Rate, and Clinical Risk
Added: 9 months ago Source:  Radcliffe Cardiology
The long-term utility of beta-blockers following an uncomplicated myocardial infarction (MI) remains a subject of clinical debate. New secondary results from the AβYSS trial (Assessment of β-blocker interruption one Year after an uncomplicated myocardial infarction on Safety and Symptomatic cardiac events requiring hospitalization) reveal that interrupting this therapy leads to sustained… View more

MI/ACS

Prevention & Chronic Conditions
AHA 24 Late-Breaking Discussion: The NUDGE-FLU Study
Author(s): Harriette Van Spall , Tor Biering-Sørensen Added: 1 year ago
AHA Conference 2024 — New insights from the NUDGE-FLU Program on electronic nudges to increase influenza vaccination amongst patients with a history of myocardial infarction.Dr Harriette Van Spall (McMaster University, CA) sits down with the principal investigator of the NUDGE-FLU trial, (NCT05542004) Dr Tor Biering-Sørensen, to discuss the latest insights and data.NUDGE-FLU is a prospective,… View more

Prevention & Chronic Conditions
Between the Sessions with Dr Parwani: CHAMPION-AF, HI-PEITHO, STEMI-DTU
Author(s): Purvi Parwani Added: 1 month ago
ACC.26 - In the first episode of Between the Sessions, Dr Purvi Parwani breaks down the biggest stories and early clinical insights from day 1 of the American College of Cardiology 2026 (ACC 2026) meeting.In this quick five‑minute recap, she highlights the trials sparking the most discussion among cardiologists – including CHAMPION‑AF, HI‑PEITHO and STEMI‑DTU – focusing on studies with the… View more

Intervention

Electrophysiology & Arrhythmia
ACC Congress 2026 Late-Breaking Science Collection
Author(s): Ann Marie Navar Added: 1 month ago
Keep up-to-date with our video collection from the American College of Cardiology's 75th Annual Scientific Session, bringing you the latest from late-breaking science, featured research, and clinical horizon sessions.Catch our congress preview and wrap-up in the NVM Cardiology Meeting Reflections series, alongside concise Expert Interviews with leading faculty distilling the key take-home… View more

Intervention

Vascular Disease and Surgery
Peripheral Sympathetic Neuromodulation for Ventricular Arrhythmias
Author(s): Léa Benabou , Marmar Vaseghi Added: 4 months ago

Electrophysiology & Arrhythmia
Higher ARR Linked to AF and Stroke Risk in Older Adults
Added: 2 months ago Source:  Radcliffe CVRM
Renin-independent aldosteronism is a common and often underrecognised condition. A new analysis from the Atherosclerosis Risk in Communities (ARIC) study has investigated whether this broader spectrum of aldosteronism is associated with incident cardiovascular disease (CVD) in older, community-dwelling adults.¹MethodologyThis prospective cohort analysis included 3,477 participants from the ARIC… View more

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
Dynamic Voltage Mapping of Ventricular Tachycardia Substrate
Author(s): Mark T Mills , Peter Calvert , Justin Chiong , et al Added: 1 year ago

Electrophysiology & Arrhythmia
ESC 24: Day 1 Wrap-Up with Dr Alasnag and Dr Al-Shaibi
Author(s): Mirvat Alasnag , Khaled Al-Shaibi Added: 1 year ago
ESC Congress 24 – Day 1 of the ESC Congress 2024 was filled with excitement as new clinical practice guidelines were unveiled, along with several highly anticipated Hot Line trials.Interventional experts Dr Mirvat Alasnag and Dr Khaled Al-Shaibi (King Fahd Armed Forces Hospital, SA) are concluding the first day by providing practical summaries of the key guidelines and offering critical insights… View more

Guidelines & Statements

Heart Failure
Ablation Beats Sotalol for VT in VANISH2 Substudy
Added: 3 months ago Source:  Arrhythmia Academy
A new substudy of the VANISH2 trial suggests that for patients with prior myocardial infarction and ventricular tachycardia (VT) who are eligible for sotalol, catheter ablation leads to better outcomes than antiarrhythmic drug (AAD) therapy.¹ For patients eligible only for amiodarone, efficacy was comparable, but amiodarone was associated with a significant increase in adverse events… View more

Electrophysiology & Arrhythmia

MI/ACS